imipramine has been researched along with triazoles in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 18 (66.67) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maj, J; Palider, W | 1 |
| Boyer, WF; D'Amico, MF; Feighner, JP; Fowler, RC; Pambakian, R | 1 |
| Udabe, RU | 1 |
| Brown, GL; Green, RL; Martin, RM | 1 |
| Horiuchi, M; Ibii, N; Yamamoto, K | 1 |
| Anton, SF; Revicki, DA | 1 |
| Preskorn, SH | 1 |
| Anton, SF; Fawcett, J; Marcus, RN; O'Brien, K; Schwiderski, U | 1 |
| Marcus, RN; Rickels, K; Roberts, DL; Robinson, DS; Schweizer, E | 1 |
| van Laar, MW; van Willigenburg, AP; Volkerts, ER | 1 |
| Anton, SF; Archibald, DG; English, PA; Kensler, TT; Roberts, DL; Robinson, DS | 1 |
| Clary, C; Fox, I; Rickels, K; Schweizer, E; Weise, C | 1 |
| Ecker, JA; Elie, R; Faludi, G; Fontaine, R; Kaplita, S; Kensler, TT; Ontiveros, A; Roberts, DL | 1 |
| Frewer, LJ; Lader, M | 1 |
| Zajecka, JM | 1 |
| Cohn, CK; Ieni, JR; O'Brien, K; Roberts, DL; Robinson, DS; Schwiderski, UE | 1 |
| Marcus, RN; Mendels, J | 1 |
| Montgomery, SA | 1 |
| Kaplita, SB; Marcus, RN; Roberts, DL; Robinson, DS; Seminara, JA; Smith, JM; Stringfellow, JC | 1 |
| Brown, RE; Clark, M; Montgomery, SA | 1 |
| Brown, RE; Culpepper, L; Gonzales, J; Hales, RE; Keller, MB; Revicki, DA | 1 |
| Anton, SF; Bakish, D; Brown, RE; Feeny, D; Palmer, W; Revicki, DA; Rosser, WW | 1 |
| Bikoff, J; Ginsberg, DL; Sussman, N | 1 |
| Carlson, G | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Ishimura, M; Iwaki, M; Tomida, T | 1 |
7 review(s) available for imipramine and triazoles
| Article | Year |
|---|---|
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depression; Diazepam; Drug Tolerance; Humans; Imipramine; Piperazines; Pyridines; Schizophrenia; Tranquilizing Agents; Triazoles | 1973 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Piperazines; Placebos; Psychomotor Agitation; Randomized Controlled Trials as Topic; Triazoles | 1995 |
Efficacy in long-term treatment of depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Imipramine; Long-Term Care; Piperazines; Placebos; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Treatment Outcome; Triazoles | 1996 |
The safety profile of nefazodone.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Piperazines; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles; Weight Gain | 1996 |
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Controlled Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Triazoles; Weight Gain | 2001 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
13 trial(s) available for imipramine and triazoles
| Article | Year |
|---|---|
A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Piperazines; Randomized Controlled Trials as Topic; Triazoles | 1989 |
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depression; Diazepam; Drug Tolerance; Humans; Imipramine; Piperazines; Pyridines; Schizophrenia; Tranquilizing Agents; Triazoles | 1973 |
Double-blind, noncrossover study of imipramine and A-10749.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Depression; Evaluation Studies as Topic; Female; Humans; Imipramine; Ketones; Male; Middle Aged; Psychiatric Status Rating Scales; Time Factors; Triazoles | 1972 |
Nefazodone: aspects of efficacy.
Topics: Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Imipramine; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Survival Analysis; Treatment Outcome; Triazoles | 1995 |
Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.
Topics: Adult; Aged; Aging; Antidepressive Agents; Automobile Driving; Cognition; Double-Blind Method; Humans; Imipramine; Multivariate Analysis; Piperazines; Psychomotor Performance; Reaction Time; Reference Values; Sleep; Triazoles | 1995 |
Long-term treatment of depression with nefazodone.
Topics: Antidepressive Agents; Chronic Disease; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Piperazines; Triazoles | 1994 |
Nefazodone and imipramine in major depression: a placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Triazoles | 1994 |
A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Patient Dropouts; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triazoles | 1994 |
The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects.
Topics: Adolescent; Adult; Antidepressive Agents; Body Temperature; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Electroencephalography; Ethanol; Female; Hemodynamics; Humans; Imipramine; Male; Memory; Piperazines; Psychomotor Performance; Reference Values; Triazoles | 1993 |
The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Community Mental Health Services; Comorbidity; Depressive Disorder; Drug Administration Schedule; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Retrospective Studies; Treatment Outcome; Triazoles | 1996 |
Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 1996 |
Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles | 1996 |
Economic analysis of treating depression with nefazodone v. imipramine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; England; Humans; Imipramine; Models, Economic; Piperazines; Recurrence; Treatment Outcome; Triazoles; Wales | 1996 |
8 other study(ies) available for imipramine and triazoles
| Article | Year |
|---|---|
Trazodone, a central serotonin antagonist and agonist.
Topics: Animals; Cyproheptadine; Dose-Response Relationship, Drug; Fenfluramine; Imipramine; Lysergic Acid Diethylamide; Male; Piperazines; Quipazine; Rats; Reflex; Serotonin; Serotonin Antagonists; Trazodone; Triazoles | 1979 |
[Pharmacology of a 1H-1, 2, 4-triazolyl benzophenone derivative (450191-S), a new sleep-inducer (III). Behavioral study on interactions of 450191-S and other drugs in mice].
Topics: Aminopyrine; Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Central Nervous System; Central Nervous System Agents; Haloperidol; Hypnotics and Sedatives; Imipramine; Male; Mice; Pentylenetetrazole; Phenytoin; Reserpine; Triazoles | 1984 |
The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
Topics: Antidepressive Agents; Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Models, Economic; Piperazines; Treatment Outcome; Triazoles | 1995 |
New perspectives in the management of depression. Symposium highlights from ECNP, Venice, September 1995.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Imipramine; Piperazines; Triazoles | 1996 |
Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder; Drug Costs; Fluoxetine; Health Care Costs; Health Policy; Health Services; Humans; Imipramine; Managed Care Programs; Patient Compliance; Piperazines; Probability; Quality-Adjusted Life Years; Treatment Failure; Treatment Outcome; Triazoles | 1997 |
Modelling the cost effectiveness of antidepressant treatment in primary care.
Topics: Antidepressive Agents; Decision Support Techniques; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Markov Chains; Models, Economic; Piperazines; Primary Health Care; Quality-Adjusted Life Years; Sensitivity and Specificity; Triazoles | 1995 |
Influence of selected inhibitors on the metabolism of the styrene metabolite 4-vinylphenol in wild-type and CYP2E1 knockout mice.
Topics: Alkynes; Animals; Animals, Wild; Benzene Derivatives; Benzoflavones; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Ditiocarb; Environmental Pollutants; Enzyme Inhibitors; Imipramine; Liver; Lung; Male; Mice; Mice, Knockout; Phenols; Styrene; Triazoles | 2004 |
A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis.
Topics: Amikacin; Amiodarone; Amitriptyline; Biological Assay; Chlorpromazine; Female; Hep G2 Cells; Humans; Imipramine; Lipidoses; Loratadine; Phospholipids; Predictive Value of Tests; Triazoles | 2017 |